-+ 0.00%
-+ 0.00%
-+ 0.00%

TEMPEST THERAPEUTICS - LICENSE PROVIDES ACCESS TO ADDITIONAL IN VIVO CAR-T CANDIDATES FOR BLOOD CANCERS, SOLID TUMORS, AUTOIMMUNE CONDITIONS

Reuters·11/11/2026 13:53:59

Please log in to view news